Literature DB >> 22392034

The role of PGC-1 and Apoε4 in insomnia.

Chien-Chuan Wang1, For-Wey Lung.   

Abstract

OBJECTIVE: Insomnia is associated with certain psychiatric illnesses such as anxiety disorder and depressive disorder. Moreover, sleep is controlled by endogenous circadian genes, which are associated with peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). In addition, apolipoprotein ε4 (Apoε4), which plays an important role in lipid metabolism, may be also associated with some mental disorders related to insomnia. The aim of this study was to investigate the role of PGC-1α in insomnia among different mental disorder groups under the control of Apoε4 and other psychosocial factors.
METHODS: A total of 202 patients with insomnia and 253 controls were recruited.
RESULTS: Logistic regression and structural equation modeling showed similar results in that with sex and age controlled, major depressive disorder, PGC-1α and Apoε4 increased the risk of insomnia. With the factors of sex, age, major depressive disorder, and Apoε4 controlled, PGC-1α still increased the risk for insomnia, showing that the GG allele of PGC-1α may play an important role in insomnia.
CONCLUSION: In the future, when treating those with insomnia and high lipid profiles, health education with regard to how to control their lipid profile maybe used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392034     DOI: 10.1097/YPG.0b013e32834dc438

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  11 in total

Review 1.  The pathophysiology of insomnia.

Authors:  Jessica C Levenson; Daniel B Kay; Daniel J Buysse
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

Review 2.  How does healthy aging impact on the circadian clock?

Authors:  Aurel Popa-Wagner; Ana-Maria Buga; Dinu Iuliu Dumitrascu; Adriana Uzoni; Johannes Thome; Andrew N Coogan
Journal:  J Neural Transm (Vienna)       Date:  2015-07-15       Impact factor: 3.575

3.  Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Authors:  Andrew S P Lim; Lei Yu; Matthew Kowgier; Julie A Schneider; Aron S Buchman; David A Bennett
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

Review 4.  Mitophagy in depression: Pathophysiology and treatment targets.

Authors:  Ashutosh Tripathi; Giselli Scaini; Tatiana Barichello; João Quevedo; Anilkumar Pillai
Journal:  Mitochondrion       Date:  2021-08-31       Impact factor: 4.160

5.  Strategies of Functional Foods Promote Sleep in Human Being.

Authors:  Yawen Zeng; Jiazhen Yang; Juan Du; Xiaoying Pu; Xiaomen Yang; Shuming Yang; Tao Yang
Journal:  Curr Signal Transduct Ther       Date:  2014-12

Review 6.  Genetic Pathways to Insomnia.

Authors:  Mackenzie J Lind; Philip R Gehrman
Journal:  Brain Sci       Date:  2016-12-20

7.  Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a).

Authors:  Lyudmila Korostovtseva; Asiiat Alieva; Oxana Rotar; Mikhail Bochkarev; Maria Boyarinova; Yurii Sviryaev; Aleksandra Konradi; Eugene Shlyakhto
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 8.  An Update on Assessment, Therapeutic Management, and Patents on Insomnia.

Authors:  Amit Porwal; Yogesh Chand Yadav; Kamla Pathak; Ramakant Yadav
Journal:  Biomed Res Int       Date:  2021-10-18       Impact factor: 3.411

Review 9.  The Sleep Side of Aging and Alzheimer's Disease.

Authors:  S M Romanella; D Roe; E Tatti; D Cappon; R Paciorek; E Testani; A Rossi; S Rossi; E Santarnecchi
Journal:  Sleep Med       Date:  2020-05-30       Impact factor: 3.492

10.  Insomnia symptom severity and cognitive performance: Moderating role of APOE genotype.

Authors:  Andrée-Ann Baril; Alexa S Beiser; Erlan Sanchez; Vincent Mysliwiec; Susan Redline; Daniel J Gottlieb; George T O'Connor; Mitzi M Gonzales; Dibya Himali; Sudha Seshadri; Jayandra J Himali; Matthew P Pase
Journal:  Alzheimers Dement       Date:  2021-07-26       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.